NCT06599840

Brief Summary

This study investigates feasibility and preliminary effects of a new behavioral parent intervention that aims to support and improve pediatric diabetes self-management

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

September 20, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

August 27, 2025

Status Verified

August 1, 2025

Enrollment Period

11 months

First QC Date

September 9, 2024

Last Update Submit

August 26, 2025

Conditions

Keywords

feasibility studytype 1 diabetesdiabetes self-managementparent supportparent interventionpediatric self-managementbehavioral interventionpediatric type 1 diabetesself-management problemsparent trainingCBTT1Dself-management intervention

Outcome Measures

Primary Outcomes (3)

  • Diabetes Treatment Satisfaction Questionnaire - parent report

    This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.

    From baseline until 26 weeks.

  • Diabetes Treatment Satisfaction Questionnaire - parent report

    This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.

    From baseline until 15 weeks.

  • Diabetes Treatment Satisfaction Questionnaire - parent report

    This is a 14 item questionnaire that aim to measure parental satisfaction with the diabetes treatment. Parents are asked to rate their satisfaction on a likert scale from 0 = very unsatisfied, to 6 = very satisfied about a range of diabetes treatment domains. The questionnaire is based on the adult version of DTSQ and adapted to pediatric type 1 diabetes. Translated to Swedish and validated in a Swedish cohort.

    Weekly from baseline to 14 weeks

Secondary Outcomes (50)

  • Glycaemic control

    From baseline until 26 weeks.

  • DISABKIDS (child QoL) - parent report

    From baseline until 26 weeks.

  • Days of physical activity

    From baseline until 26 weeks.

  • PedsQL - Family Impact Measure (parent QoL)

    From baseline until 26 weeks.

  • Me As Parent

    From baseline until 26 weeks.

  • +45 more secondary outcomes

Study Arms (1)

Intervention group

OTHER

CBT-based parent intervention consisting of 7 group sessions.

Behavioral: Parent intervention

Interventions

This is a novel intervention based on established CBT-based parenting strategies that are regularly used to strengthen parent-child cooperation and reduce conflicts. Here, the strategies are adapted to address typical challenges of T1D family life. The program structure consists of six weekly modules and a seventh booster module. Each of the first six modules has a theme with information on a parental strategy associated with the theme, self-reflective questions, and an assignment where parents plan to implement the strategy during the upcoming week. One month later, a seventh session is held to summarize the program and make plans for future progress.

Intervention group

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Parents/guardians of children aged 9-14 with type 1 diabetes.
  • The child has had type 1 diabetes for at least one year.
  • The parent experience difficulties in managing daily life and/or the parent-child collaboration around self-management routines.
  • The perceived difficulties should not solely be due to perceived problems in the medical aspects of the diabetes treatment, such as a perceived need for more support in insulin dosing, more diabetes education, or technical/medical support. This criterion is based solely on the subjective judgement of the parent him-/herself.
  • The child receives diabetes care at one of the three diabetes clinics in the Stockholm Region.
  • The parent speaks, understands, and can read Swedish.
  • The parent claims to be motivated and has the practical possibility to participate in the study and attend group meetings.

You may not qualify if:

  • The parent reports current and severe psychiatric conditions in themselves or the child that need to be prioritized, such as severe depression, suicidal thoughts/self-harm, psychosis, or mania.
  • The parent is involved in another psychological treatment of a behavior-changing nature that is in an active phase, either concerning themselves or a child.
  • Major planned changes in diabetes treatment that require learning and behavioral changes, such as transitioning from pen to pump, and that are expected to occur during the first 3.5 months of the study (active intervention phase).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska University Hospital

Stockholm, 17164, Sweden

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Brjánn Ljótsson, Professor

    Karolinska Institute, Department of Clinical Neuroscience, Division of Psychology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, licensed psychologist

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

September 20, 2024

Primary Completion

August 19, 2025

Study Completion

November 1, 2025

Last Updated

August 27, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

European GDPR regulation prevents sharing of IDP

Locations